VR Logo

Lumos Pharma Inc. (LUMO) download report


Healthcare | Biotechnology & Pharma Research

Lumos Pharma Inc. (LUMO) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases.

IPO Date: 11-Nov-2011

CEO & Chairman: Mr. Richard J. Hawkins

Chief Scientific Officer & Pres: Dr. John C. McKew Ph.D.

Listing: NASDAQ: LUMO

Country: United States

Headquarters: Austin, TX

Website: https://www.lumos-pharma.com

Key Facts

Market cap: $64.36 Mln

Revenue (TTM): $0.11 Mln

Earnings (TTM): $-29.52 Mln

Cash: $86.76 Mln

Total Debt: $0.48 Mln

Insider's Holding: 33.46%

Liquidity: Low

52 Week range: $6.15 - 11.52

Shares outstanding: 8,369,230

10 Years Aggregate:

  • CFO: $-196.33 Mln
  • EBITDA: $-245.46 Mln
  • Net Profit: $-251.41 Mln

Stock Performance

Time Period Lumos Pharma (LUMO) S&P BSE Sensex S&P Small-Cap 600
YTD10.97-9.18-18.78
1 month-2.04-4.78-8.00
3 months-18.19-9.66-13.65
1 Year-23.100.81-17.19
3 Years-16.7310.336.10
5 Years-34.9811.345.87
10 Years-24.9011.749.84
As on 01-Jul-2022
Year Lumos Pharma (LUMO) S&P Small-Cap 600 S&P BSE Sensex
2021-80.5925.2721.99
202056.839.5715.75
201966.4520.8614.38
2018-81.09-9.705.87
2017-21.1111.7327.91
2016-71.7524.741.95
2015-8.45-3.36-5.03